Skip to main content

LOTENSIN HCT 453 453 Pill - purple capsule/oblong, 12mm

Pill with imprint LOTENSIN HCT 453 453 is Purple, Capsule/Oblong and has been identified as Benazepril Hydrochloride and Hydrochlorothiazide 20 mg / 12.5 mg. It is supplied by Rising Pharmaceuticals.

Benazepril/hydrochlorothiazide is used in the treatment of High Blood Pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Benazepril/hydrochlorothiazide 20 mg / 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LOTENSIN HCT 453 453

Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg LOTENSIN HCT 453 453
Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg LOTENSIN HCT 453 453
Benazepril hydrochloride and hydrochlorothiazide 20 mg / 12.5 mg LOTENSIN HCT 453 453

Benazepril Hydrochloride and Hydrochlorothiazide

Imprint
LOTENSIN HCT 453 453
Strength
20 mg / 12.5 mg
Color
Purple
Size
12.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
ACE inhibitors with thiazides
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Rising Pharmaceuticals
Inactive Ingredients
microcrystalline cellulose, crospovidone, hydrogenated castor oil, ferric oxide red, lactose, polyethylene glycol, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
64980-0195 Rising Pharmaceuticals, Inc.
30698-0453 Validus Pharmaceuticals LLC

Get help with Imprint Code FAQs.

Related images for "LOTENSIN HCT 453 453"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.